Narayana Hrudayalaya Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Narayana Hrudayalaya (NSE: NH) is preparing to announce its fourth quarter FY26 (Q4 FY26) financial results for the period ended March 31, 2026. The board of directors is scheduled to meet on May 2026 (Expected) to approve the audited financial statements for Q4 FY26 and consider a recommendation for a final dividend for FY26 shareholder approval.

With Narayana Hrudayalaya trading at a current market price of Rs 1,360 — down from a 52-week high of Rs 1,600 and a 1-year return of -8% — the Q4 FY26 results will be a pivotal moment for investors deciding whether to hold, add, or reduce their position. Analyst estimates for Q4 FY26 revenue stand at Rs 1,550–1,650 Cr, with PAT expectations of Rs 185–215 Cr and margin projections of EBITDA 21–23%.

This article covers the Narayana Hrudayalaya Q4 results 2026 date, detailed earnings estimates, five key performance factors, five risks to monitor, analyst ratings and price targets, and answers to the most commonly searched investor questions ahead of the announcement.

Narayana Hrudayalaya Q4 Results 2026 Date

Get free investment predictions and live Q4 result alerts. Sign up on .

Narayana Hrudayalaya has scheduled its Q4 FY26 results for May 2026 (Expected). The board of directors will meet to approve the audited consolidated financial statements for the quarter and full year ended March 31, 2026. The trading window for designated employees is closed until 48 hours after the results announcement, as per SEBI regulations.

Here is how the broader Q4 FY26 earnings calendar looks for large-cap Indian companies in April–May 2026:

Source: BSE/NSE exchange filings, April 2026. Expected dates may change. Verify before relying.

Why This Quarter Matters for Narayana Hrudayalaya Investors

Narayana Hrudayalaya enters Q4 FY26 — the quarter ending March 31, 2026 — with expectations of 12–16% revenue growth YoY. Q4 is typically a seasonally important quarter as companies execute on year-end targets, government orders pick up, and annual dividend recommendations are made. For Narayana Hrudayalaya, specifically, Q4 FY26 matters because the stock has delivered a -8% 1-year return against a backdrop of broader market volatility and sector-specific headwinds.

Every quarterly result tells a story, but Narayana Hrudayalaya’s Q4 FY26 print will be watched closely because it sets the baseline for FY27 estimates, determines full-year FY26 performance, and provides the first clear read on whether the business momentum is accelerating or decelerating. Management guidance on margins, volumes, and capital allocation will be just as important as the headline PAT number.

Narayana Hrudayalaya Q4 FY26 Earnings Estimates

Narayana Hrudayalaya Q4 FY26 analyst estimates at a glance. Source: MOFSL, YES Securities, JM Financial.

Access premium SEBI-registered research on .

Brokerages including MOFSL, YES Securities, JM Financial, and others have published their Q4 FY26 preview estimates for Narayana Hrudayalaya. The consensus expects Rs 1,550–1,650 Cr in revenue for Q4 FY26, compared to Rs 1,401 Cr in Q3 FY26. Profit after tax (PAT) is estimated at Rs 185–215 Cr, with margin expectations of EBITDA 21–23%. Growth momentum on the key volume/activity metric is projected at 12–16% revenue growth YoY.

Beyond the headline numbers, investors will watch closely for: management commentary on FY27 revenue growth guidance, any revision in margin trajectory, updates on order book or deal pipeline, and capex or investment plans. A positive surprise on any two of these four parameters could drive a meaningful post-results re-rating.

Screen  and historical financials on .

5 Key Factors That Will Drive Narayana Hrudayalaya Q4 FY26 Performance

Revenue Momentum and Order Pipeline

Narayana Hrudayalaya enters Q4 FY26 with a strong foundation built on consistent order wins and improving demand across key segments. Analysts expect Q4 revenue of Rs 1,550–1,650 Cr, driven by execution on existing orders and seasonal demand pickup. The management team’s commentary on the pipeline and deal wins will set the direction for FY27 estimates and investor sentiment heading into the new financial year.

Margin Trajectory and Cost Control

Margin improvement is one of the most closely watched metrics heading into Narayana Hrudayalaya’s Q4 FY26 results. Analysts have pencilled in EBITDA 21–23% for the quarter. Input cost trends, employee expense efficiency, and pricing power in key markets will collectively determine whether the company can sustain or improve on Q3’s EBITDA 21.4% margin. Any margin beat here would be a meaningful positive catalyst for the stock.

Profitability Growth and PAT Estimates

Narayana Hrudayalaya’s Q4 FY26 PAT is expected in the range of Rs 185–215 Cr. This would reflect the improvement in both top-line growth and operating leverage. Investors will look closely at the effective tax rate, any one-time charges or reversals, and the quality of reported profit. A clean PAT print—free of non-recurring items—would be most positively received by institutional investors tracking the stock.

Management Guidance for FY27

Perhaps the most consequential output from the Q4 FY26 results announcement will be management guidance for FY27. Growth expectations, margin bands, capex plans, and any commentary on macro risks will significantly influence how the street values Narayana Hrudayalaya over the next 12 months. Given the current global macro uncertainty, clear and credible guidance will be valued more than usual.

Dividend and Capital Allocation Signal

Narayana Hrudayalaya is expected to consider a final dividend of Rs 4–6 per share expected at the Q4 FY26 board meeting. The dividend declaration signals management’s confidence in the company’s cash flow strength and financial position. Investors tracking dividend yield will also assess whether the payout ratio signals any change in the company’s capital allocation philosophy heading into FY27.

5 Risks to Watch in Narayana Hrudayalaya Q4 FY26

Macro and Global Demand Uncertainty

Narayana Hrudayalaya operates in an environment shaped by global macro conditions including US Federal Reserve policy, rupee volatility, crude oil prices, and geopolitical developments. Any deterioration in demand conditions — particularly in export-facing segments — could lead to lower-than-expected revenue and margin performance in Q4 FY26. Investors should monitor management’s commentary on demand visibility for FY27.

Margin Pressure from Cost Headwinds

Rising employee costs, input material price volatility, and technology investment needs can compress margins despite revenue growth. Narayana Hrudayalaya’s ability to absorb these cost headwinds through pricing or productivity improvements will determine the quality of Q4 FY26 earnings. Any unexpected cost escalation could result in a PAT miss even if revenue is broadly in line with estimates.

Execution and Delivery Risk

Translating a strong pipeline and order book into recognised revenue requires smooth operational execution across teams, supply chains, and client delivery cycles. Any delays — whether from client-side decision-making, supply chain disruption, or internal capacity constraints — could push revenue recognition into FY27, creating a near-term earnings shortfall despite fundamentals remaining intact.

Regulatory and Compliance Risks

Companies across sectors in India operate within a framework of evolving SEBI, RBI, and sector-specific regulations. Changes in tax norms, compliance requirements, or government policy could affect Narayana Hrudayalaya’s profitability and operational flexibility. Investors should track any regulatory announcements relevant to the Healthcare / Hospitals sector alongside quarterly results for a complete picture.

Competitive Intensity and Market Share Risk

Narayana Hrudayalaya faces competition from domestic and international players in its core markets. Pricing pressure, product innovation by competitors, and shifting customer preferences can erode market share over time. Management’s commentary on competitive dynamics — and the company’s response strategy — will be an important signal about long-term earnings durability heading into FY27.

Narayana Hrudayalaya Share Price and Analyst Ratings

Narayana Hrudayalaya is trading at Rs 1,360 as of early April 2026, against a 52-week high of Rs 1,600 and a 52-week low of Rs 1,050. The market capitalisation stands at Rs 27,800 Cr. The 1-year return of -8% reflects the broader Healthcare / Hospitals sector headwinds alongside company-specific factors. The Q4 FY26 results and FY27 guidance will be critical in determining whether the stock can recover toward analyst consensus targets.

Download the  or  to track Narayana Hrudayalaya’s live price and receive real-time Q4 result alerts when the board declares results.

Conclusion

Narayana Hrudayalaya Q4 FY26 results on May 2026 (Expected) will be a key event for investors monitoring the Healthcare / Hospitals sector. Analysts project PAT of Rs 185–215 Cr and revenue of Rs 1,550–1,650 Cr, representing continued sequential growth from Q3 FY26 levels. At a CMP of Rs 1,360 and with analyst targets ranging from Rs 1,680 to Rs 1,700, the stock offers meaningful risk-reward for informed investors. FY27 guidance commentary will be the most critical post-results catalyst.

This analysis is based on publicly available analyst estimates and company filings. Actual Q4 FY26 results may differ materially from consensus estimates. Market reactions to results depend not only on the reported numbers but also on management guidance, peer performance, and broader macro sentiment. Investing ahead of quarterly results carries earnings risk — the stock can fall on a miss or rise sharply on a beat.

For more Q4 FY26 previews across IT, banking, auto, pharma, and cement sectors, visit .

Frequently Asked Questions

What is the Narayana Hrudayalaya Q4 results 2026 date?

The Narayana Hrudayalaya Q4 results 2026 date is May 2026 (Expected). The board of directors will meet on this date to approve the audited Q4 FY26 financial results — covering the quarter ended March 31, 2026 — and will consider a dividend recommendation for FY26.

What is the Narayana Hrudayalaya Q4 FY26 PAT estimate?

Analysts estimate Narayana Hrudayalaya Q4 FY26 net profit (PAT) in the range of Rs 185–215 Cr. This estimate is based on revenue assumptions of Rs 1,550–1,650 Cr and a margin of EBITDA 21–23%. Actual results may differ from these consensus estimates.

What is Narayana Hrudayalaya’s share price ahead of Q4 results?

Narayana Hrudayalaya shares are trading at approximately Rs 1,360 as of early April 2026. The 52-week high is Rs 1,600 and the 52-week low is Rs 1,050. The one-year return is -8% and the market cap stands at Rs 27,800 Cr.

Will Narayana Hrudayalaya declare a dividend in Q4 2026?

Narayana Hrudayalaya is expected to consider a dividend of Rs 4–6 per share expected at the Q4 FY26 board meeting on May 2026 (Expected). This would be the final dividend for FY26, subject to shareholder approval at the upcoming Annual General Meeting.

Which analysts have a Buy rating on Narayana Hrudayalaya?

MOFSL (Buy, target Rs 1,700), YES Securities (Buy, target Rs 1,650), JM Financial (Add, target Rs 1,550), ICICI Direct (Buy, target Rs 1,680) are among the brokerages with positive ratings on Narayana Hrudayalaya heading into Q4 FY26 results. Ratings and targets are based on publicly available research notes and are subject to change.

What were Narayana Hrudayalaya Q3 FY26 results?

Narayana Hrudayalaya reported Q3 FY26 (October–December 2025) revenue of Rs 1,401 Cr and PAT of Rs 168 Cr, with margin at EBITDA 21.4%. The Q3 FY26 results provided the base against which Q4 FY26 estimates have been built by analysts.

When do Infosys and TCS announce Q4 results 2026?

TCS declared Q4 FY26 results on April 9, 2026. For the full TCS Q4 results preview, visit the  on Univest Blogs. Infosys Q4 FY26 results are scheduled for April 23, 2026. Read the full  on Univest Blogs for detailed estimates, analyst ratings, and FY27 guidance expectations.

Is Narayana Hrudayalaya a good investment ahead of Q4 results?

This depends on your risk appetite, investment horizon, and portfolio context. Narayana Hrudayalaya has both compelling factors and genuine near-term risks — both are covered in detail in this article. Consult a SEBI-registered financial advisor before making any investment decision. Use the Univest Screener to assess Narayana Hrudayalaya fundamentals independently before investing.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information including NSE/BSE filings and company investor relations pages. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.

Recent Article

Ambuja Cements Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Power Grid Corporation of India Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Tech Mahindra Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Adani Ports SEZ Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Titan Company Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook